Enovis CORP (ENOV) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2025, Enovis reported revenue of $2.25B, up 6.7% from $2.11B the year before. Net income was -$1.18B (a -52.7% net margin), or -$20.75 per diluted share. Gross margin was 59.8% and operating margin was -50.0%. Operating activities generated $217.3M of cash, leaving $19.9M of free cash flow. At fiscal year end, Enovis held $3.83B in total assets against $2.34B in total liabilities, including $36.4M of cash and equivalents.
Open the full interactive Enovis financials → Quarterly statements, key ratios, valuation history and price charts.
Enovis Key Stats
| Share Price | $18.99 |
|---|---|
| Market Cap | $1.09B |
| Revenue YoY Growth | +6.7% |
| 52-Week Range | $17.43 – $32.87 |
| Shares Outstanding | 57.6 million (basic, 2026 Q2) |
Enovis Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $3.07B | $3.85B | $1.56B | $1.71B | $2.11B | $2.25B |
| Cost of Goods Sold | $1.78B | $2.24B | $693.7M | $716.4M | $926.9M | $902.8M |
| Gross Profit | $1.29B | $1.61B | $869.4M | $990.8M | $1.18B | $1.35B |
| Operating Income | $162.3M | $256.6M | -$71.2M | -$65.7M | -$775.7M | -$1.12B |
| Pre-Tax Income | $58.0M | $165.4M | -$2.1M | -$67.1M | -$822.9M | -$1.16B |
| Income Tax | -$6.1M | $66.7M | $36.1M | -$13.3M | $4.5M | $22.3M |
| Net Income | $42.6M | $71.7M | -$13.3M | -$33.3M | -$825.5M | -$1.18B |
| Diluted EPS | $0.31 | $0.46 | -$0.25 | -$0.61 | -$14.93 | -$20.75 |
Enovis Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $548.9M | $575.8M | $589.2M | $582.8M |
| Net Income | -$571.1M | -$520.6M | -$8.8M | -$1.2M |
| Diluted EPS | -$9.99 | -$9.12 | -$0.15 | -$0.02 |
Enovis Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $97.1M | $719.4M | $24.3M | $36.2M | $48.2M | $36.4M |
| Current Assets | $1.36B | $2.30B | $795.0M | $896.5M | $1.15B | $1.21B |
| Total Assets | $7.35B | $8.52B | $4.27B | $4.51B | $4.72B | $3.83B |
| Current Liabilities | $811.7M | $1.02B | $565.2M | $369.6M | $529.0M | $598.5M |
| Total Long-Term Debt | $2.23B | $2.09B | $259.3M | $466.2M | $1.33B | $1.30B |
| Total Liabilities | $3.76B | $3.85B | $823.4M | $1.09B | $2.15B | $2.34B |
| Shareholders' Equity | $3.54B | $4.62B | $3.45B | $3.42B | $2.56B | $1.49B |
Enovis Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $301.9M | $356.1M | -$55.9M | $135.0M | $113.5M | $217.3M |
| Cash From Investing | -$175.1M | -$320.5M | -$176.4M | -$242.5M | -$955.5M | -$179.4M |
| Cash From Financing | -$131.7M | $584.9M | -$465.1M | $127.8M | $846.8M | -$52.4M |
| Free Cash Flow | $187.2M | $251.9M | -$161.3M | $12.8M | -$67.2M | $19.9M |
Figures from Enovis' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Enovis financials page for every line item.
Enovis Company Profile
| Ticker | ENOV |
|---|---|
| Exchange | NYSE |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | Lewisville, Texas |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001420800 |
Frequently Asked Questions
What was Enovis' revenue in fiscal 2025?
Enovis (ENOV) reported revenue of $2.25B for fiscal 2025.
What is Enovis' annual revenue history?
Enovis' annual revenue by fiscal year: 2020: $3.07B; 2021: $3.85B; 2022: $1.56B; 2023: $1.71B; 2024: $2.11B; 2025: $2.25B.
What was Enovis' net income in fiscal 2025?
Enovis reported net income of -$1.18B for fiscal 2025.
What was Enovis' earnings per share (EPS) in fiscal 2025?
Enovis' diluted EPS was -$20.75 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Enovis generate in fiscal 2025?
Enovis generated $19.9M of free cash flow in fiscal 2025.
What was Enovis' revenue last quarter?
In its most recent reported quarter (2026 Q2), Enovis reported revenue of $582.8M.
How much debt does Enovis have?
Enovis reported $1.30B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Enovis are outstanding?
Enovis reported a weighted average of 57.6 million basic shares outstanding in 2026 Q2.
What is Enovis' market cap?
Based on its latest closing price, Enovis (ENOV) has a market capitalization of about $1.09B.
When does Enovis' fiscal year end?
Enovis' fiscal year end, as registered with the SEC, is December 31.
Where is Enovis headquartered?
Enovis lists its business address in Lewisville, Texas in its SEC filings.
Enovis Competitors & Similar Companies
See all 20 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies →